Clinical Nutrition

Market Development Baxter Clinical Evidence Generation $10M investment to support therapy adoption & differentiation¹ Optimal feeding through supplemental PN leads to faster recovery and lowers cost of care Higher protein in PN provides more energy & reduces ventilator days in the ICU by as much as 2 days iCAN Portfolio Innovation ¿A Development Adjacencies + Peer-to-Peer Educational Programs Sustained investment reaching 7,000 clinicians by 2023 3X increase in understanding of PN benefits after program 88% more likely to prescribe PN therapy as result of program participation Clinical Evidence And Education Drive Sustainable Base Business Growth ¹Planned 2018 - 2023 cumulative investment. | 9

View entire presentation